Globe Life Inc. (NYSE:GL) Given Consensus Rating of “Moderate Buy” by Brokerages

Globe Life Inc. (NYSE:GL) has been given a consensus rating of “Moderate Buy” by the eleven research firms that are currently covering the firm, Marketbeat Ratings reports. Two analysts have rated the stock with a hold recommendation, eight have given a buy recommendation and one has given a strong buy recommendation to the company. The average 1-year target price among brokers that have updated their coverage on the stock in the last year is $191.6667.

GL has been the topic of several recent analyst reports. TD Cowen lifted their target price on shares of Globe Life from $215.00 to $225.00 and gave the stock a “buy” rating in a report on Wednesday, July 22nd. Piper Sandler upped their price target on shares of Globe Life from $175.00 to $200.00 and gave the company an “overweight” rating in a report on Wednesday, July 15th. Morgan Stanley raised their price target on Globe Life from $181.00 to $208.00 and gave the company an “overweight” rating in a research report on Monday, July 6th. Weiss Ratings lowered Globe Life from a “buy (b)” rating to a “buy (b-)” rating in a research note on Monday, July 20th. Finally, Keefe, Bruyette & Woods cut their price objective on Globe Life from $192.00 to $190.00 and set an “outperform” rating for the company in a research report on Friday, July 24th.

Globe Life Trading Down 0.0%

Shares of NYSE GL opened at $184.08 on Wednesday. The company has a quick ratio of 0.07, a current ratio of 0.07 and a debt-to-equity ratio of 0.38. Globe Life has a 12 month low of $127.85 and a 12 month high of $191.55. The company has a market cap of $14.29 billion, a price-to-earnings ratio of 12.22 and a beta of 0.48. The business has a fifty day simple moving average of $172.62 and a 200-day simple moving average of $154.94.

Globe Life (NYSE:GL) last announced its earnings results on Wednesday, July 22nd. The company reported $3.61 earnings per share (EPS) for the quarter, missing the consensus estimate of $3.67 by ($0.06). The firm had revenue of $1.60 billion for the quarter, compared to analyst estimates of $1.59 billion. Globe Life had a net margin of 19.58% and a return on equity of 20.73%. Globe Life’s revenue for the quarter was up 8.0% compared to the same quarter last year. During the same period last year, the firm earned $3.05 earnings per share. Globe Life has set its FY 2026 guidance at 15.550-15.950 EPS. Sell-side analysts predict that Globe Life will post 15.7 EPS for the current year.

Insider Buying and Selling at Globe Life

In other Globe Life news, CFO Thomas Peter Kalmbach sold 25,650 shares of the business’s stock in a transaction on Tuesday, July 28th. The shares were sold at an average price of $178.58, for a total value of $4,580,577.00. Following the sale, the chief financial officer owned 50,568 shares of the company’s stock, valued at $9,030,433.44. The trade was a 33.65% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, Director Cheryl Alston sold 8,258 shares of the stock in a transaction on Thursday, June 25th. The shares were sold at an average price of $179.24, for a total transaction of $1,480,163.92. Following the completion of the transaction, the director owned 16,621 shares of the company’s stock, valued at approximately $2,979,148.04. This represents a 33.19% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold 219,174 shares of company stock valued at $37,675,349 in the last three months. Company insiders own 2.11% of the company’s stock.

Hedge Funds Weigh In On Globe Life

A number of hedge funds have recently modified their holdings of GL. Vanguard Group Inc. raised its stake in shares of Globe Life by 0.9% in the fourth quarter. Vanguard Group Inc. now owns 10,090,885 shares of the company’s stock valued at $1,411,311,000 after acquiring an additional 86,349 shares during the last quarter. Invesco Ltd. grew its position in Globe Life by 2.7% during the 4th quarter. Invesco Ltd. now owns 3,948,676 shares of the company’s stock worth $552,262,000 after acquiring an additional 102,445 shares during the last quarter. Dimensional Fund Advisors LP increased its holdings in Globe Life by 10.2% during the 1st quarter. Dimensional Fund Advisors LP now owns 2,353,192 shares of the company’s stock valued at $327,479,000 after purchasing an additional 217,331 shares in the last quarter. Morgan Stanley increased its holdings in Globe Life by 7.2% during the 4th quarter. Morgan Stanley now owns 1,860,257 shares of the company’s stock valued at $260,176,000 after purchasing an additional 125,567 shares in the last quarter. Finally, Arrowstreet Capital Limited Partnership raised its position in Globe Life by 32.9% in the 4th quarter. Arrowstreet Capital Limited Partnership now owns 1,435,247 shares of the company’s stock valued at $200,734,000 after purchasing an additional 355,399 shares during the last quarter. 81.61% of the stock is owned by institutional investors and hedge funds.

Globe Life Company Profile

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.